Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Clinical trial NCT03447132 · COMPLETED
Trial details
- NCT number
- NCT03447132
- Sponsor
- International Cancer Research Group, United Arab Emirates
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2021-04-12
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.